
bluebird bio, Inc.
USD4.97
+0.00 (+0.00%)
CEO
Andrew Obenshain
IPO Date
2013-06-19
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.97
Prev. Close
$4.97
Day Low
$4.97
Day High
$4.97
52W Low
$3.20
52W High
$28.60
Market Cap
$0.05B
Volume
1.25M
| 31 Dec 2024 |
| Barclays |
| Overweight |
| Overweight |
| maintain |
| 15 Nov 2024 | B of A Securities | Buy | Neutral | downgrade |
| 15 Nov 2024 | RBC Capital | Sector Perform | Sector Perform | maintain |
| 15 Nov 2024 | Barclays | Overweight | Overweight | maintain |
| 25 Sept 2024 | Wells Fargo | Equal Weight | Equal Weight | maintain |
| 15 Aug 2024 | JP Morgan | Overweight | Neutral | downgrade |
| 15 Aug 2024 | Barclays | Overweight | Overweight | maintain |